[ORGANIZATION]
Genmab
Featured in 3 tracked stories · first seen
Situations
Genmab clinical trial developments
2 clusters · 8 sources · last updated
Latest: Genmab petosemtamab combination reduces head and neck cancer death risk by 50%
Genmab A/S has reported positive clinical trial results for multiple investigational treatments. Initial reports highlighted Phase 1/2 data for the antibody-drug conjugate rinatabart sesutecan (Rina-S) in treating platin
Also covered in
-
C25 Index remains stable as Genmab shares surge
[BUSINESS] · 2 sources ·
-
AbbVie and Genmab report 51% reduction in lymphoma progression risk
[BUSINESS] · 4 sources ·